Comments on: Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine

Comments on: Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine https://insideout.vn/dupixent-dupilumab-late-breaking-data-from-notus-confirmatory-phase-3-copd-trial-presented-at-ats-and-published-in-the-new-england-journal-of-medicine/ Inside Out Mon, 20 May 2024 18:15:00 +0000 hourly 1 https://wordpress.org/?v=6.6.2